Who Paid My Doc
Gregory Buford
Plastic and Reconstructive Surgery Lone Tree, CO Medical Doctor
NPI 1558302380 CMS profile 1062143
10459 Park Meadows Dr, Ste 100, Lone Tree, CO 80124
General payments
$300,970
Research payments
$0
Ownership & investment interest
$75
Through program year 2025, Gregory Buford of Lone Tree, CO is reported in the CMS Open Payments database as having received $300,970 across 401 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $75 across 3 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
10 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $74,881 | 63 | |
| 2024 | General | $4,872 | 37 | |
| 2023 | General | $42,478 | 37 | |
| 2022 | General | $54,657 | 72 | |
| 2021 | General | $9,478 | 63 | |
| 2020 | General | $21,147 | 44 | |
| 2019 | General | $93,456 | 85 | |
| 2024 | Ownership | $25 | 1 | |
| 2022 | Ownership | $25 | 1 | |
| 2021 | Ownership | $25 | 1 |
Beside peers
- Gregory Buford
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Gregory Buford were reported at $74,881. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Gregory Buford | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $93,456 | $335 | $121–$1,264 | $163 |
| 2020 | $21,147 | $162 | $57–$417 | $114 |
| 2021 | $9,478 | $245 | $89–$735 | $132 |
| 2022 | $54,657 | $325 | $120–$932 | $149 |
| 2023 | $42,478 | $343 | $129–$999 | $160 |
| 2024 | $4,872 | $390 | $141–$1,085 | $164 |
| 2025 | $74,881 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
401 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in Colorado
Christodoulos Kaoutzanis
Plastic and Reconstructive Surgery · Aurora, CO
David Mathes
Plastic and Reconstructive Surgery · Aurora, CO
Jarom Gilstrap
Plastic and Reconstructive Surgery · Denver, CO
Jeremy Williams
Plastic and Reconstructive Surgery · Lone Tree, CO
Mark Greyson
Plastic and Reconstructive Surgery · Aurora, CO
Julian Winocour
Plastic and Reconstructive Surgery · Aurora, CO
Related records
Plastic and Reconstructive Surgery in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.